Protak Scientific manufacture Enzyme Indicator technology (EIs), a rapid validation tool for gaseous bio-decontamination. EIs were originally developed in collaboration with Public Health England (now the UK Health Security Agency). One of Protak Scientific’s largest sectors is Pharmaceutical Manufacturing, where they partner with over 80% of the largest global companies.
They also provide validation consultancy to multiple sectors where bio-decontamination is critical to ensure safety and efficacy. Part of the technology is a specially developed software, ATHENA™, that delivers real-time quantifiable results for cycle efficacy. This offers enhanced reporting and review features that support compliance requirements.
The technology can help companies in various sectors design manufacturing facilities, build bespoke equipment or manage quality assurance of pharmaceutical production, providing customers with the most effective method of bio-decontamination validation.
ATHENA™, our bespoke software, delivers real-time quantifiable results for cycle efficacy with FDA 21 CFR Part 11 compliance reporting.
ATHENA™ is used alongside Enzyme Indicators to deliver advanced reporting capability, enhanced audit and review features along with data archive facilities during validation cycles. It can act as an early warning system allowing proactive execution and planning to occur.
We are working alongside many of the largest pharmaceutical companies, creating a standardised approach to H₂O₂ bio-decontamination validation. This groups includes AstraZeneca, Baxter, Bayer, Novo Nordisk, Sanofi, Pfizer and Roche.
Following the changes of EU GMP Annex 1: Manufacture of Sterile Medicinal Products, we brought together an industry working group to discuss the new requirements.
The group aims to share knowledge and deliver the following objectives:
Read about the advantages and benefits of using our Enzyme Indicators for your H₂O₂ bio-decontamination validation processes.
Biological Indicators vs Enzyme Indicators at a glance.
Presentations, white papers, webinars, shared articles, project summaries and product analysis.